Efficacy of ''Malva sylvestrison functional constipation .
- Conditions
- constipation.constipation
- Registration Number
- IRCT2014031617032N1
- Lead Sponsor
- Faculty of Traditional Medicines,Tehran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 110
Men and women aged 18–65 as having at least two or more of the following, during 25% of defecation times: very hard and/or hard stools; sensation of incomplete evacuation; straining at defecation; a need for digital manipulation to facilitate evacuation.These criteria should have been fulfilled for the 3 previous months with symptom onset at least 6 months prior to diagnosis.
Exclusion criteria:Men and women <18 years;Men and women>65 years;patients with mentioned criteria & drug-induced constipation, patients suffering from secondary causes of chronic constipation, including endocrine, metabolic, or neurological disorders; patients with a history of gastrointestinal surgery(exception of appandectomy and cholecystectomy); those with a diagnosis of constipation dominant IBS; Patients with alarming symptoms (fever, recent weight loss , and anaemia)& constipation.
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Defecation rate per week on average. Timepoint: before interventing &2,4 weeks aftertreatment. Method of measurement: ROME III questionnaire.;Hard stools. Timepoint: before interventing & 2,4 weeks aftertreatment. Method of measurement: ROME III questionnaire& Bristol stool form scale.;Need for digital manipulation to facilitate evacuation. Timepoint: before interventing & 2,4 weeks aftertreatment. Method of measurement: ROME III questionnaire.;Sensation of blockage. Timepoint: before interventing & 2,4 weeks aftertreatment. Method of measurement: ROME III questionnaire.;Straining of defecation. Timepoint: before interventing & 2,4 weeks aftertreatment. Method of measurement: ROME III questionnaire.
- Secondary Outcome Measures
Name Time Method Rarely dyspepcia. Timepoint: every time patient reports. Method of measurement: patient report.